1/30/09 update
Stocks were unable to follow up on Wednesday's rally and Wall Street had little to show for a week's worth of trading. They had even less to show for the month, with the S&P 500's drop of -8.6% being the worst January performance on record.
At Friday's close, the Nasdaq Composite Index was down -6.06% CYTD, or "Contest Year To Date" (vs. down -6.00% CYTD a week ago). However, the Nasdaq Biotech Index actually advanced a bit for the week, closing up 2.06% CYTD (vs. down -1.32% CYTD a week ago). The Contest median also had an Ok week, closing up .58% CYTD (vs. down -3.08% CYTD a week ago).
ENZYME's portfolio held on to first place, closing the week up 16.35% CYTD. SCARAM's portfolio beat out my own for second place with an 11.62 % CYTD gain.
At Friday's close, 17 of the 32 Contest portfolios were in the black and 13 of the 32 beat the NBI.
Enjoy the weekend folks!
Below is the Top Ten list on 1/30/09:
1/30/09
Rank Name Profit/Loss
1 ENZYME 16,352
2 SCARAM 11,627
3 BULBA 10,797
4 GEORGIA 7,573
5 GHMM 7,058
6 STEVEL 7,017
7 THEOX 5,837
8 RKRW 5,228
9 FILO 4,725
10 ROBERT 4,626
(All corrections, especially adjustments for splits, greatly appreciated.) |
